Monday, June 20, 2016

BRIEF-Cellectis says first patient treated in phase 1 trial of UCART19

* Cellectis SA says first patient treated in phase 1 trial

of ucart19 in pediatric acute B lymphoblastic leukemia

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)